221 – 230 of 482
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2010
-
Mark
1/4 av all vård är onödig eller skadlig
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
OARSI recommendations for the management of hip and knee osteoarthritis. Part III : Changes in evidence following systematic cumulative update of research published through January 2009.
(
- Contribution to journal › Article
- 2009
-
Mark
Variations in the pre-operative status of patients coming to primary hip replacement for osteoarthritis in European orthopaedic centres
(
- Contribution to journal › Article
-
Mark
Whither osteoarthritis biomarkers?
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
OARSI/OMERACT Criteria of Being Considered a Candidate for Total Joint Replacement in Knee/Hip Osteoarthritis as an Endpoint in Clinical Trials Evaluating Potential Disease Modifying Osteoarthritic Drugs
2009) 9th International Consensus Conference on Outcome Measures in Rheumatology Clinical Trails (OMERACT 9) 36(9). p.2097-2099(
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
-
Mark
Resistin is elevated following traumatic joint injury and causes matrix degradation and release of inflammatory cytokines from articular cartilage in vitro
(
- Contribution to journal › Article
-
Mark
Choosing surgery: patients' preferences within a trial of treatments for anterior cruciate ligament injury. A qualitative study
(
- Contribution to journal › Article
-
Mark
Incidence of severe knee and hip osteoarthritis in relation to different measures of body mass. A population-based prospective cohort study.
(
- Contribution to journal › Article
-
Mark
Multi-language translation and cross-cultural adaptation of the OARSI/OMERACT measure of intermittent and constant osteoarthritis pain (ICOAP)
(
- Contribution to journal › Article
-
Mark
Synovial fluid level of aggrecan ARGS fragments is a more sensitive marker of joint disease than glycosaminoglycan or aggrecan levels: a cross-sectional study
(
- Contribution to journal › Article